SEZABY approved by US FDA for the treatment of neonatal seizures EP News Bureau Nov 18, 2022 First and only product approved for treating neonatal seizures
Sun Pharma and SPARC enter into licence agreement for commercialisation of phenobarbital for… EP News Bureau Nov 10, 2022 Product awaiting the US FDA approval, targetted at treating seizures in neonatal patients
Glenmark, Sun Pharma and two others recall products in US Press Trust of India Aug 16, 2022 As per the latest Enforcement Report by the US Food and Drug Administration (FDA), Glenmark is recalling over 6.5 lakh tubes of a…
Sun Pharma Chairman, Israel Makov to retire this month EP News Bureau Aug 3, 2022 Makov helped steer the company to pursue its strategy of building a global pipeline of specialty products
Sun Pharma Q1 results: Net profit up 43 per cent to Rs 2,061 crores on robust sales Press Trust of India Jul 29, 2022 The company had posted a net profit of Rs 1,444 crores in April-June 2021-22
Sun Pharma, Glenmark recall drugs in US due to manufacturing deviations Press Trust of India Jul 25, 2022 Sun Pharma is recalling 50,680 vials of Testosterone Cypionate Injection, while Glenmark is recalling 98,307 packs of Mometasone…
Sun Pharma to expand field force in India by 10 per cent this fiscal Press Trust of India Jun 6, 2022 The company currently employs around 11,000 Medical Representatives (MRs) and related staff in the country
Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania EP News Bureau May 31, 2022 Financial terms of the transaction are confidential
Sun Pharma recalls more than 10,000 bottles of generic anti-depression drug in US Press Trust of India May 23, 2022 The drug is used to treat depression and prevent Seasonal Affective Disorder (SAD)
Sun Pharma plans to launch oral lipid-lowering drug Brillo in India EP News Bureau May 18, 2022 Brillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents